Send us Feedback

NMT Medical (NMTI)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

NMTI » Topics » Summary Compensation Table

This excerpt taken from the NMTI DEF 14A filed Apr 24, 2009.

Summary Compensation Table

 

The following table sets forth information concerning compensation earned during the fiscal years ended December 31, 2008, December 31, 2007 and December 31, 2006 by our former President and Chief Executive Officer, Mr. Ahern, and Mr. Davis who was our Chief Financial Officer during fiscal 2008 and has also been our Chief Operating Officer since February 9, 2009. We refer to these executives as our “Named Executives” elsewhere in this proxy statement.

 

Name and Principal Position

    Year
    Salary
($)
    Stock
Awards
($)(1)
     Option
Awards
($)(2)
    Non-Equity
Incentive Plan
Compensation
($)(3)
     All Other
Compensation
($)
     Total
($)

John E. Ahern(4)

    2008    460,000    —       161,941    55,200     31,853 (5)   708,994

Former President and Chief

    2007    416,000    —       136,343    55,000     16,587 (6)   623,930

Executive Officer

    2006    400,000    —       180,712    —       18,420 (7)   599,132

Richard E. Davis

    2008    359,000    14,080 (8)   42,440    —   (8)   —       415,520

Chief Operating Officer and

    2007    339,721    —       22,764    43,000     —       405,485

Chief Financial Officer

    2006    300,000    —       43,003    135,000     6,600 (9)   484,603
(1) The amounts included in the “Stock Awards” column are calculated as the number of shares awarded multiplied by the closing price of the common stock as reported by the NASDAQ Global Market on the date of the grant.
(2) The amounts included in the “Option Awards” column are based on the dollar amount recognized for financial statement reporting purposes pursuant to the Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment” (“FAS 123R”) with respect to fiscal 2008, 2007 and 2006. For additional information regarding the assumptions used by us with respect to the valuation of option awards refer to Note 9—“Share-Based Compensation” in the Notes to the Consolidated Financial Statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and Note 10—“Share-Based Compensation” in the Notes to the Consolidated Financial Statements contained in our Annual Report on Form 10-K for the fiscal years ended December 31, 2007 and 2006.
(3) Reflects a payment pursuant to Mr. Ahern’s and Mr. Davis’ employment agreements upon the Joint Compensation and Options Committee determination of performance objectives attainment. Please see “Compensation Discussion and Analysis—Performance-Based Cash Incentive Awards” elsewhere in this proxy statement for additional information regarding Mr. Ahern’s and Mr. Davis’ performance-based cash incentive awards. These amounts were earned in the fiscal year noted but paid in the first quarter of the next fiscal year.
(4) Mr. Ahern retired as President, Chief Executive Officer and Director effective February 9, 2009, and Mr. Martin, a member of our Board was appointed our President and Chief Executive Officer on that day.
(5) Consists of a car allowance of $18,000 and $13,853 paid by the Company as a reimbursement for payments made by Mr. Ahern during 2008 for his health insurance policy with Cigna Healthcare.
(6) Consists of a monthly car allowance effective October 18, 2007 of $3,692 and $12,895 paid by the Company as a reimbursement for payments made by Mr. Ahern during 2007 for his health insurance policy with Cigna Healthcare.
(7) Consists of 401(k) employer matching contributions of $6,600 paid on Mr. Ahern’s behalf and $11,820 paid by the Company as reimbursement for the payments made by Mr. Ahern during 2006 for his health insurance policy with Cigna Healthcare.
(8) A stock award of 22,000 shares was granted to Mr. Davis on March 17, 2009 in lieu of a performance-based cash incentive award for performance during fiscal 2008.
(9) Consists of 401(k) employer matching contributions paid on Mr. Davis’ behalf.

 

22

Table of Contents
This excerpt taken from the NMTI DEF 14A filed Apr 29, 2008.

Summary Compensation Table

 

The following table sets forth information concerning compensation for the fiscal years ended December 31, 2007 and December 31, 2006 for services in all capacities earned by the Named Executives.

 

Name and Principal Position

   Year
   Salary ($)
   Bonus
($)
   Stock
Awards
($)
   Option
Awards
($)(1)
   Non-Equity
Incentive Plan
Compensation
($)(2)
   Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings ($)
   All Other
Compensation
     Total ($)

John E. Ahern

   2007   $ 416,000   —     —     $ 136,343   $ 55,000   —     $ 16,587 (3)   $ 623,930

President and Chief Executive Officer

   2006   $ 400,000   —     —     $ 180,712     —     —     $ 18,420 (4)   $ 599,132

Richard E. Davis

   2007   $ 339,721   —     —     $ 22,764   $ 43,000   —       —       $ 405,485

Executive Vice President and Chief Financial Officer

   2006   $ 300,000   —     —     $ 43,003   $ 135,000   —     $ 6,600 (5)   $ 484,603
(1) The amounts included in the “Option Awards” column are based on the dollar amount recognized for financial statement reporting purposes pursuant to the Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment” (“FAS 123R”) with respect to fiscal 2007 and 2006. For additional information regarding the assumptions used by us with respect to the valuation of option awards refer to Note 10—“Share-Based Compensation” in the Notes to the Consolidated Financial Statements contained in our Annual Report on Form 10-K for the fiscal years ended December 31, 2007 and 2006.
(2) Reflects a payment pursuant to Mr. Ahern’s and Mr. Davis’ employment agreements upon the Joint Compensation and Options Committee determination of performance objectives attainment. Please see “Compensation Discussion and Analysis—Performance-Based Cash Incentive Awards” elsewhere in this proxy statement for additional information regarding Mr. Ahern’s and Mr. Davis’ performance-based cash incentive awards. These amounts were earned in the fiscal year noted but paid in the first quarter of the next fiscal year.
(3) Consists of a monthly car allowance effective October 18, 2007 of $3,692 and $12,895 paid by the Company as a reimbursement for payments made by Mr. Ahern during 2007 for his health insurance policy with Cigna Healthcare.
(4) Consists of 401(k) employer matching contributions of $6,600 paid on Mr. Ahern’s behalf and $11,820 paid by the Company as reimbursement for the payments made by Mr. Ahern during 2006 for his health insurance policy with Cigna Healthcare.
(5) Consists of 401(k) employer matching contributions paid on Mr. Davis’ behalf.

 

This excerpt taken from the NMTI DEF 14A filed Apr 30, 2007.

Summary Compensation Table

 

The following table sets forth information concerning compensation during the year ended December 31, 2006 for services in all capacities earned by the Named Executives:

 

Name and Principal

Position

   Year
   Salary ($)
   Bonus
($)
   Stock
Awards
($)
   Option
Awards
($) (1)
   Non-Equity
Incentive Plan
Compensation
($)
     Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings ($)
   All Other
Compensation
     Total ($)

John E. Ahern

President, Chief

Executive Officer and Chairman

   2006   $ 400,000   —     —     $ 102,676     —       —     $ 19,495 (2)   $ 522,171

Richard E. Davis

Executive Vice

President and Chief

Financial Officer

   2006   $ 300,000   —     —       —     $ 135,000 (3)   —     $ 6,600 (4)   $ 441,600
(1) The amounts included in the “Option Awards” column are based on the dollar amount recognized for financial statement reporting purposes pursuant to the Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment” (“FAS 123(R)”) with respect to fiscal 2006. For additional information regarding the assumptions used by us with respect to the valuation of option awards, refer to Footnote 10—“Share-Based Compensation” in the Notes to the Consolidated Financial Statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006, which is on file with the SEC.
(2) Consists of 401(k) employer matching contributions of $6,600 paid on Mr. Ahern’s behalf and $12,895 paid by the Company as reimbursement for the payments made by Mr. Ahern during 2006 for his health insurance policy with Cigna Healthcare.
(3) Reflects a payment pursuant to Mr. Davis’ employment agreement upon the Joint Compensation and Options Committee’s determination of performance objectives attainment. Please see “Compensation Discussion and Analysis—Performance-Based Cash Incentive Awards” elsewhere in this proxy statement for additional information regarding Mr. Davis’ performance-based cash incentive awards. This amount was earned in fiscal 2006 but paid in the first quarter of 2007.
(4) Consists of 401(k) employer matching contributions paid on Mr. Davis’ behalf.

 

This excerpt taken from the NMTI DEF 14A filed Apr 27, 2006.

Summary Compensation Table

 

The following table sets forth certain information concerning the compensation for each of the last three years for the Company’s Chief Executive Officer and its other most highly compensated executive officers whose total annual salary and bonus exceeded $100,000 in the year ended December 31, 2005 (collectively, the “Named Executives”).

 

     Annual Compensation(1)
    Long-Term
Compensation
Awards
        

Name and Principal Position

    Year
    Salary
($)
     Bonus
($)
    Number of Securities
Underlying Stock
Options (#)(2)
     All Other
Compensation ($)
  

John E. Ahern

President and Chief

Executive Officer

    2005
2004
2003		    $
 
 		 350,000
350,000
350,000		  
 
 		   $
 
 		 150,000
52,500
90,000		    25,000
—  
—  		 (3)
 
 		   $
 
 		 5,883
—  
—  		 (4)
 
 

Richard E. Davis

Vice President and Chief

Financial Officer

    2005
2004
2003		    $
 
 		 297,577
276,250
246,875		 (5)
(8)
(10)		   $
 
 		 100,000
75,000
91,000		    19,000
18,000
20,000		 (6)
(9)
(11)		   $
 
 		 5,883
—  
—  		 (7)
 
 
(1) In accordance with the rules of the Commission, other compensation in the form of perquisites and other personal benefits has been omitted in those instances where such perquisites and other personal benefits did not exceed the lesser of $50,000 or ten percent of the total of annual salary and bonus for the Named Executive in question for the fiscal year.
(2) The Company has never granted any stock appreciation rights.
(3) Consists of an option to purchase 12,500 shares of Common Stock at an exercise price of $10.05 per share and an option to purchase 12,500 shares of Common Stock at an exercise price of $7.80 per share.
(4) Represents a one-time matching contribution made pursuant to the Company’s 401(k) plan.
(5) Reflects a base salary of $280,000 per year for the period January 1, 2005 through February 13, 2005, and $300,000 for the period February 14, 2005 through December 31, 2005. See “Employment and Severance Agreements.”
(6) Consists of an option to purchase 19,000 shares of Common Stock at an exercise price of $16.34 per share.
(7) Represents a one-time matching contribution made pursuant to the Company’s 401(k) plan.
(8) Reflects a base salary of $250,000 per year for the period January 1, 2004 through February 13, 2004, and $280,000 for the period February 14, 2004 through December 31, 2004. See “Employment and Severance Agreements.”
(9) Consists of an option to purchase 18,000 shares of Common Stock at an exercise price of $3.50 per share.
(10) Reflects a base salary of $225,000 per year for the period January 1, 2003 through February 13, 2003, and $250,000 for the period February 14, 2003 through December 31, 2003. See “Employment and Severance Agreements.”
(11) Consists of an option to purchase 20,000 shares of Common Stock at an exercise price of $4.19 per share.

 

15

This excerpt taken from the NMTI DEF 14A filed May 18, 2005.

Summary Compensation Table

 

The following table sets forth certain information concerning the compensation for each of the last three years for the Company’s Chief Executive Officer and its other most highly compensated executive officers whose total annual salary and bonus exceeded $100,000 in the year ended December 31, 2004 (collectively, the “Named Executives”).

 

     Annual Compensation
    Long-Term
Compensation
Awards
      

Name and Principal Position

    Year
    Salary
($)
     Bonus
($)
    Number of Securities
Underlying Stock
Options (#)(1)
     All Other
Compensation ($)(2)

John E. Ahern

President and Chief

Executive Officer

    2004
2003
2002		    $
 
 		 350,000
350,000
350,000		  
 
 		   $
 
 		 52,500
90,000
97,500		    —  
—  
190,000		  
 
(3)		   —  
—  
—  

Richard E. Davis

Vice President and Chief

Financial Officer

    2004
2003
2002		     
 
 		 276,250
246,875
220,894		 (4)
(6)
(8)		    
 
 		 75,000
91,000
85,000		    18,000
20,000
70,000		 (5)
(7)
(9)		   —  
—  
—  
(1) The Company has never granted any stock appreciation rights.
(2) In accordance with the rules of the Commission, other compensation in the form of perquisites and other personal benefits has been omitted in those instances where such perquisites and other personal benefits did not exceed the lesser of $50,000 or ten percent of the total of annual salary and bonus for the Named Executive in question for the fiscal year.
(3) Consists of an option to purchase 50,000 shares of Common Stock at an exercise price of $6.60 per share, an option to purchase 75,000 shares of Common Stock at an exercise price of $3.03 per share, and an option to purchase 65,000 shares of Common Stock at an exercise price of $2.97 per share, which option was granted in February 2003 as a 2002 bonus.
(4) Reflects a base salary of $250,000 per year for the period January 1, 2004 through February 13, 2004, and $280,000 for the period February 14, 2004 through December 31, 2004. See “Employment and Severance Agreements”.
(5) Consists of an option to purchase 18,000 shares of Common Stock at an exercise price of $3.50 per share.
(6) Reflects a base salary of $225,000 per year for the period January 1, 2003 through February 13, 2003, and $250,000 for the period February 14, 2003 through December 31, 2003. See “Employment and Severance Agreements”.
(7) Consists of an option to purchase 20,000 shares of Common Stock at an exercise price of $4.19 per share.
(8) Reflects a base salary of $190,000 per year for the period January 1, 2002 through February 13, 2002, and $225,000 for the period February 14, 2002 through December 31, 2002. See “Employment and Severance Agreements”.
(9) Consists of an option to purchase 30,000 shares of Common Stock at an exercise price of $6.60 per share and an option to purchase 40,000 shares of Common Stock at an exercise price of $5.76 per share.

 

14

This excerpt taken from the NMTI 10-K filed Mar 23, 2005.

Summary Compensation Table

 

The following table sets forth certain information concerning the compensation for each of the last three years for our Chief Executive Officer and our other most highly compensated executive officers whose total annual salary and bonus exceeded $100,000 in the year ended December 31, 2004 (collectively, the “Named Executives”).

 

Name and Principal Position

   

Annual

Compensation

    Long-Term
Compensation
Awards
     All Other
Compensation
($) (2)
   Year
   

Salary

($)

     Bonus
($)
    Number of
Securities
Underlying Stock
Options (#) (1)
    

John E. Ahern
President and Chief
Executive Officer

    2004
2003
2002		    $
 
 		 350,000
350,000
350,000		  
 
 		   $
 
 		 52,500
90,000
97,500		    —  
—  
190,000		  
 
(3)		   —  
—  
—  

Richard E. Davis
Vice President and
Chief Financial Officer

    2004
2003
2002		     
 
 		 276,250
246,875
220,894		 (4)
(6)
(8)		    
 
 		 75,000
91,000
85,000		    18,000
20,000
70,000		 (5)
(7)
(9)		   —  
—  
—  
(1) We have never granted any stock appreciation rights.
(2) In accordance with the rules of the Commission, other compensation in the form of perquisites and other personal benefits has been omitted in those instances where such perquisites and other personal benefits did not exceed the lesser of $50,000 or ten percent of the total of annual salary and bonus for the Named Executive in question for the fiscal year.
(3) Consists of an option to purchase 50,000 shares of Common Stock at an exercise price of $6.60 per share, an option to purchase 75,000 shares of Common Stock at an exercise price of $3.03 per share, and an option to purchase 65,000 shares of Common Stock at an exercise price of $2.97 per share, which option was granted in February 2003 as a 2002 bonus.
(4) Reflects a base salary of $250,000 per year for the period January 1, 2004 through February 13, 2004, and $280,000 for the period February 14, 2004 through December 31, 2004. See “Employment and Severance Agreements”.
(5) Consists of an option to purchase 18,000 shares of Common Stock at an exercise price of $3.50 per share.
(6) Reflects a base salary of $225,000 per year for the period January 1, 2003 through February 13, 2003, and $250,000 for the period February 14, 2003 through December 31, 2003. See “Employment and Severance Agreements”.
(7) Consists of an option to purchase 20,000 shares of Common Stock at an exercise price of $4.19 per share.
(8) Reflects a base salary of $190,000 per year for the period January 1, 2002 through February 13, 2002, and $225,000 for the period February 14, 2002 through December 31, 2002. See “Employment and Severance Agreements”.
(9) Consists of an option to purchase 30,000 shares of Common Stock at an exercise price of $6.60 per share and an option to purchase 40,000 shares of Common Stock at an exercise price of $5.76 per share.

 

38

EXCERPTS ON THIS PAGE:

DEF 14A
Apr 24, 2009
DEF 14A
Apr 29, 2008
DEF 14A
Apr 30, 2007
DEF 14A
Apr 27, 2006
DEF 14A
May 18, 2005
10-K
Mar 23, 2005

RELATED TOPICS for NMTI:

"Summary Compensation Table" elsewhere:

Antares Pharma (AIS)
MGC DIAGNOSTICS Corp (ANGN)
BioLase Technology (BLTI)
Cardica (CRDC)
Home Diagnostics (HDIX)
ICU Medical (ICUI)
ERBA Diagnostics, Inc. (IVD)
Memry (MRY)
NUCRYST Pharmaceuticals (NCST)
NeuroMetrix (NURO)
Oculus Innovative Sciences (OCLS)
Pro-Dex (PDEX)
Rochester Medical (ROCM)
Retractable Technologies (RVP)
Strategic Diagnostics (SDIX)
STEN (STEN)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki